Clinical Trial Update: A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701

View source ↗

Summary

A completed clinical trial evaluating management of HIV-1-infected patients who test positive for the HLA-B*5701 genetic marker.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ziagen (Abacavir)

Snippet

Sponsor: GlaxoSmithKline | Conditions: HIV Infection | Status: COMPLETED